Terms: = Skin cancer AND CRTC3, FLJ21868, 64784, ENSG00000140577, TORC3
4 results:
1. crtc3, a sensor and key regulator for melanogenesis, as a tunable therapeutic target for pigmentary disorders.
Yoo H; Lee HR; Kim KH; Kim MA; Bang S; Kang YH; Kim WH; Song Y; Chang SE
Theranostics; 2021; 11(20):9918-9936. PubMed ID: 34815795
[No Abstract] [Full Text] [Related]
2. Dasatinib Stimulates Its Own Mechanism of Resistance by Activating a crtc3/MITF/Bcl-2 Pathway in Melanoma with Mutant or Amplified c-Kit.
Sabbah M; Krayem M; Najem A; Sales F; Miller W; Del Rincon S; Awada A; Ghanem GE; Journe F
Mol Cancer Res; 2021 Jul; 19(7):1221-1233. PubMed ID: 33741716
[TBL] [Abstract] [Full Text] [Related]
3. A novel fusion gene crtc3-MAML2 in hidradenoma: histopathological significance.
Kuma Y; Yamada Y; Yamamoto H; Kohashi K; Ito T; Furue M; Oda Y
Hum Pathol; 2017 Dec; 70():55-61. PubMed ID: 29079171
[TBL] [Abstract] [Full Text] [Related]
4. Cutaneous hidradenoma: a study of 21 neoplasms revealing neither correlation between the cellular composition and CRTC1-MAML2 fusions nor presence of crtc3-MAML2 fusions.
Kyrpychova L; Kacerovska D; Vanecek T; Grossmann P; Michal M; Kerl K; Kazakov DV
Ann Diagn Pathol; 2016 Aug; 23():8-13. PubMed ID: 27402217
[TBL] [Abstract] [Full Text] [Related]
